Related Experiment Video
Updated: Apr 24, 2026

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in
Megha Prasad1, Martin Reriani1, Sundeep Khosla1
1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Insights
Coronary microvascular endothelial dysfunction (CMED) in postmenopausal women is a significant predictor of future osteoporosis. This early sign of coronary atherosclerosis indicates a doubled risk for developing bone loss, highlighting a link between vascular and bone health.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Gerontology
Background:
- Growing evidence links coronary artery disease and osteoporosis in women.
- Endothelial function is crucial for vascular integrity and may influence bone metabolism.
- The study investigates if early coronary atherosclerosis, indicated by coronary microvascular endothelial dysfunction (CMED), predicts osteoporosis development.
Purpose of the Study:
- To determine if CMED predicts osteoporosis in postmenopausal women.
- To explore the relationship between vascular health and bone density in aging women.
- To identify early markers for osteoporosis risk in women with non-obstructive coronary arteries.
Main Methods:
- 194 postmenopausal women over 50 with non-obstructive coronary arteries underwent coronary vascular reactivity testing.
- Coronary microvascular endothelial dysfunction (CMED) was defined as a ≤50% increase in coronary blood flow post-acetylcholine.
- Osteoporosis development was assessed via questionnaire after a median 7.0-year follow-up.
Main Results:
- Women with CMED were twice as likely to develop osteoporosis (RR 2.4, 95% CI 1.1-5.6, P=0.02) after adjusting for confounders.
- Epicardial endothelial dysfunction did not show an association with osteoporosis development.
- The findings suggest CMED is a significant risk factor for osteoporosis in this cohort.
Conclusions:
- Coronary microvascular endothelial dysfunction serves as an independent marker for osteoporosis risk in postmenopausal women.
- This study reinforces the connection between coronary atherosclerosis and osteoporosis.
- Early detection of endothelial dysfunction may aid in identifying women at higher risk for osteoporosis.
Background:
A growing body of evidence links coronary artery atherosclerosis and calcification to osteoporosis in women. The endothelium plays a critical role in maintaining vascular integrity and may play a role in bone metabolism. We aimed to determine whether early coronary atherosclerosis, as detected by coronary microvascular endothelial dysfunction (CMED), predicts the development of osteoporosis in postmenopausal women.
Methods:
Coronary vascular reactivity was evaluated in 194 postmenopausal women greater than 50 years of age and with non-obstructive coronary arteries by administration of intracoronary acetylcholine during diagnostic angiography. CMED was defined as ≤50% increase in coronary blood flow from baseline in response to maximal dose. After a median follow-up of 7.0±0.3 years, patients were assessed by a questionnaire for development of osteoporosis.
Results:
The average age of the cohort was 60.9±7.4 years. Women with CMED were twice as likely to develop osteoporosis compared with women without endothelial dysfunction after adjustment for potential confounders (relative risk, 2.4; 95% confidence interval [CI], 1.1, 5.6, P=0.02). Epicardial endothelial dysfunction was not associated with development of osteoporosis.
Discussion:
Early coronary atherosclerosis with endothelial dysfunction is an independent marker for increased risk of developing osteoporosis in postmenopausal women greater than 50 years of age without obstructive coronary artery disease. The current study supports a link between coronary atherosclerosis and osteoporosis.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Coronary Artery Disease II: Pathophysiology
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Coronary Artery Disease I: Introduction
Bone Remodeling
